Abstract
To the Editor: Poornima et al1 recently reported prolonged survival and preserved ventricular function through chronic treatment with glucagon-like peptide-1 (GLP-1) in spontaneously hypertensive, heart failure-prone rats. The authors explained their findings by insulinotropic effect of GLP-1, that is, augmented insulin secretion causes increased Akt-phosphorylation, consequently reducing cardiomyocyte apoptosis and increasing glucose transporter (GLUT)-4 translocation and myocardial glucose uptake. We believe that some methodological weaknesses question the conclusions and that the results suggest a different mechanism of action. The data on Akt phosphorylation and …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
